LetopCS® Chondroitin Sulfate Oligosaccharide

Product Overview:

Chondroitin Sulfate Oligosaccharide (LetopCS®) is a low-molecular-weight chondroitin sulfate produced using patented bio-enzymatic hydrolysis technology. Through precise molecular weight control, LetopCS® features an optimized molecular size while retaining the characteristic structural features of chondroitin sulfate, supporting its absorption and utilization in the body.

Key Features:

① Optimized small-molecule structure with potential benefits for absorption and utilization

② U.S. GRAS recognition

③ Supported by multiple academic studies in the pharmaceutical field

④Patent Certifications from Five Major Regions

US Invention Patent No. US11572421B2

China Invention Patent No. ZL201910264385.5

Russian Invention Patent No. 2843181

Australian Invention Patent No. AU 2020374934B2

European Invention Patent No. EP3933037

Key Advantages:

① Small-molecule structural design to enhance absorption and utilization potential

② U.S. GRAS Certification, Global Patent Portfolio

③ Supported by multiple academic research papers in the field of pharmacy

Specifications:

CAS：9082-07-9

Average Molecular Weight: ≤1 kDa

Content: ≥90%

Appearance: Pale yellow to yellow powder

Functional Properties

Supports joint comfort and flexibility

Helps maintain normal joint mobility

Supports healthy cartilage cell maintenance

Provides nutritional support for cartilage structure and integrity

Functional descriptions are intended for food and dietary supplement applications.

Application
Functional Foods

Dietary Supplements

Nutrition Products

Category: Nutraceuticals & Food Ingredients